A Study to Characterize the Absorption, Metabolism, and Excretion of 14C-JNJ-53718678 After a Single Oral Dose in Healthy Male Participants
Clinical trial NCT03002779 · COMPLETED
Trial details
- NCT number
- NCT03002779
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-26
- Primary completion
- 2017-03-10
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.